Cite
Evaluation of a multi‐agent chemotherapy protocol combining lomustine, procarbazine and prednisolone (LPP) for the treatment of relapsed canine non‐Hodgkin high‐grade lymphomas.
MLA
Tanis, J.‐b., et al. “Evaluation of a Multi‐agent Chemotherapy Protocol Combining Lomustine, Procarbazine and Prednisolone (LPP) for the Treatment of Relapsed Canine Non‐Hodgkin High‐grade Lymphomas.” Veterinary & Comparative Oncology, vol. 16, no. 3, Sept. 2018, pp. 361–69. EBSCOhost, https://doi.org/10.1111/vco.12387.
APA
Tanis, J. ‐b., Mason, S. L., Maddox, T. W., Blackwood, L., Killick, D. R., Amores, fuster, I., Harper, A., & Finotello, R. (2018). Evaluation of a multi‐agent chemotherapy protocol combining lomustine, procarbazine and prednisolone (LPP) for the treatment of relapsed canine non‐Hodgkin high‐grade lymphomas. Veterinary & Comparative Oncology, 16(3), 361–369. https://doi.org/10.1111/vco.12387
Chicago
Tanis, J.‐b., S. L. Mason, T. W. Maddox, L. Blackwood, D. R. Killick, fuster, I. Amores, A. Harper, and R. Finotello. 2018. “Evaluation of a Multi‐agent Chemotherapy Protocol Combining Lomustine, Procarbazine and Prednisolone (LPP) for the Treatment of Relapsed Canine Non‐Hodgkin High‐grade Lymphomas.” Veterinary & Comparative Oncology 16 (3): 361–69. doi:10.1111/vco.12387.